Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing micafungin (Mycamine) to itraconazole for preventing fungal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itraconazole (Itraconazole)
  • Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Fungemia, Fungal Infections | Phase 3 | Status: COMPLETED